<PAGE> 1
PROSPECTUS SUPPLEMENT FILED PURSUANT TO RULE 424(b)(3)
TO PROSPECTUS DATED JUNE 14, 1999 REGISTRATION NO. 333-75865
SOLECTRON CORPORATION
$1,656,000,000
LIQUID YIELD OPTION(TM) NOTES (ZERO COUPON -- SENIOR) DUE 2019
AND
THE COMMON STOCK ISSUABLE UPON CONVERSION OF THE LYONS
This Prospectus Supplement relates to the resale by the holders (the
"Selling Securityholders") of Liquid Yield Option(TM) Notes (Zero Coupon --
Senior) due 2019 (the "LYONs") of Solectron Corporation (the "Company") and the
shares of Common Stock, par value of $.001 per share (the "Common Stock"), of
the Company issuable upon the conversion thereof (the "Conversion Shares").
This Prospectus Supplement should be read in conjunction with the
Prospectus dated June 14, 1999, which is to be delivered with this Prospectus
Supplement. All capitalized terms used but not defined in the Prospectus
Supplement shall have the meanings given them in the Prospectus.
The table below sets forth information as of the date hereof about the
principal amount at maturity of the LYONs and the underlying common stock
beneficially owned by each Selling Securityholder of the LYONs that may be
offered using this prospectus. All information concerning beneficial ownership
has been furnished by the Selling Securityholders.
<TABLE>
<CAPTION>
Principal Amount
at Maturity of Number of
LYONs Percentage of Shares of Percentage of
Beneficially Owned LYONs Common Stock Common Stock
Name That May Be Sold Outstanding That May Be Sold (1) Outstanding (2)
---- ------------------ ------------- -------------------- ---------------
<S> <C> <C> <C> <C>
Merrill Lynch International $24,175,000 * 180,636 *
LTD
Merrill Lynch, Pierce, Fenner $200,000 * 1,494 *
and Smith, Inc.
Merrill Lynch, Pierce, Fenner $6,050,000 * 45,206 *
and Smith, Inc.
Goldman Sachs and Company $300,000 * 2,242 *
Salomon Smith Barney, Inc. $5,850,000 * 43,711 *
CDC Financial Products $11,000,000 * 82,192 *
</TABLE>
-----------
* Less than 1%
(1) Assumes conversion of all of the holder's LYONs at a conversion rate of
7.472 shares of common stock per $1,000 principal amount at maturity of
the LYONs. However, this conversion rate will be subject to adjustment as
described under "Description of LYONs -- Conversion Right." As a result,
the amount of common stock issuable upon conversion of the LYONs may
increase or decrease in the future.
(2) Calculated based on Rule 13d-3(d)(i) of the Exchange Act using 601,514,000
shares of common stock outstanding as of November 3, 2000. In calculating
this amount, we treated as outstanding the number of shares of common
stock issuable upon conversion of all of that particular holder's LYONs.
However, we did not assume the conversion of any other holder's LYONs.
-------------------
FOR A DISCUSSION OF CERTAIN FACTORS THAT SHOULD BE CONSIDERED IN CONNECTION
WITH AN INVESTMENT IN THE SECURITIES OFFERED HEREBY, SEE "RISK FACTORS"
BEGINNING ON PAGE 6 OF THE PROSPECTUS.
-------------------
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE
SECURITIES AND EXCHANGE COMMISSION NOR HAS THE SECURITIES
AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMIS-
SION PASSED UPON THE ACCURACY OR ADEQUACY OF THIS
PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY
IS A CRIMINAL OFFENSE.
-------------------
The date of this Prospectus Supplement is November 3, 2000.
---------------
(TM)Trademark of Merrill Lynch & Co.
